Keywords: pharmacyclics, ph, iii, trial, mri, agent, initiated

Pharmacyclics Ph III Trial For MRI Agent

Article | 03 October 1994

Print This

Pharmacyclics has initiated a Phase III trial of its Gadolite oral suspension magnetic resonance imaging agent in the diagnosis of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in